Centanni, L.; Cicerone, C.; Fanizzi, F.; D’Amico, F.; Furfaro, F.; Zilli, A.; Parigi, T.L.; Peyrin-Biroulet, L.; Danese, S.; Allocca, M.
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches. Pharmaceuticals 2025, 18, 78.
https://doi.org/10.3390/ph18010078
AMA Style
Centanni L, Cicerone C, Fanizzi F, D’Amico F, Furfaro F, Zilli A, Parigi TL, Peyrin-Biroulet L, Danese S, Allocca M.
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches. Pharmaceuticals. 2025; 18(1):78.
https://doi.org/10.3390/ph18010078
Chicago/Turabian Style
Centanni, Lucia, Clelia Cicerone, Fabrizio Fanizzi, Ferdinando D’Amico, Federica Furfaro, Alessandra Zilli, Tommaso Lorenzo Parigi, Laurent Peyrin-Biroulet, Silvio Danese, and Mariangela Allocca.
2025. "Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches" Pharmaceuticals 18, no. 1: 78.
https://doi.org/10.3390/ph18010078
APA Style
Centanni, L., Cicerone, C., Fanizzi, F., D’Amico, F., Furfaro, F., Zilli, A., Parigi, T. L., Peyrin-Biroulet, L., Danese, S., & Allocca, M.
(2025). Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches. Pharmaceuticals, 18(1), 78.
https://doi.org/10.3390/ph18010078
